Asthma drug could stop cat allergy sneezes in their tracks

NCT ID NCT06069063

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This small Phase 2 trial tests whether a single dose of zafirlukast, an asthma drug, can prevent nasal symptoms caused by cat dander. Twelve adults with cat allergies will receive either the drug or a placebo before being exposed to cat dander in a controlled setting. Their symptoms will be tracked for four hours to see if the drug makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Zafirlukast

What this could lead to

If it works, this could point toward a new way to prevent allergy symptoms from cats using an already-approved asthma drug.

What could go wrong

This is a very small early-stage trial with only 12 people. It may not work as hoped, and results may not apply to real-world cat exposure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGY TO CATS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••